4//SEC Filing
Matheis Dennis 4
Accession 0001104659-23-057160
CIK 0001533998other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:13 PM ET
Size
6.9 KB
Accession
0001104659-23-057160
Insider Transaction Report
Form 4
Matheis Dennis
Director
Transactions
- Purchase
Series B-2 Preferred Stock
2023-05-04$1000.00/sh+50$50,000→ 50 totalExercise: $3.37From: 2023-05-04Exp: 2026-05-04→ Common Stock
Holdings
- 82,620
Common Stock
Footnotes (2)
- [F1]The Series B Preferred Stock will automatically convert into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date.
- [F2]The Series B Preferred Stock initially converts into shares of common stock at a conversion price of $3.37. In addition, the holders of Series B Preferred Stock will also be entitled dividends payable as follows: (i) a number of shares of Common Stock equal to five percent (5.0%) of the number of shares of Common Stock issuable upon conversion of the Series B Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the closing date, and (ii) a number of shares of common stock equal to ten percent (10%) of the number of shares of common stock issuable upon conversion of the Series B Preferred Stock then held by such holder on the fifth full quarter from the closing date.
Documents
Issuer
DarioHealth Corp.
CIK 0001533998
Entity typeother
Related Parties
1- filerCIK 0001817012
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 4:13 PM ET
- Size
- 6.9 KB